US Stock Futures Decline as Bond Yields Fall Following Reports of Putins Updated Nuclear Doctrine TSMC Flirts With Buy Point on AI Demand Price Hike Plans TJX Companies Attracts Analyst Attention Amid Evolving Retail Landscape K Wave Media Schedules Annual Meeting Proposes Charter Amendments Tulsi Gabbard Steps Down as US Intelligence Chief Amid Family Health Concerns Mastercard Secures New York BitLicense Expanding Crypto Footprint Sypris Solutions Inc SYPR Q3 2025 Earnings Company Posts Positive EPS Amid Limited Disclosures AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges MOLN Q4 2025 Earnings Positive EPS Surprise Amid No Revenue RGNX Q1 2026 Earnings WiderthanExpected Loss and Absent Revenue Weigh on Shares Dawson Geophysical Q2 2019 Earnings EPS Misses Estimates Amid Challenging Environment Redwood Trust Senior Notes RWTN Inch Higher Yield Attraction and Technical Support in Focus Tantech Holdings TANH Stock Holds Steady at 042 Key Levels in Focus Akso Health Group AHG Shows Modest Decline Amid Light Trading Reborn Coffee REBN Slips 16 as Stock Hovers Between Key Support and Resistance KRAKacquisition Corp KRAQ Holds Steady at 992 Amid Quiet Trading Oppenheimer Initiates Granite Construction Coverage with Outperform Rating Electra Battery Materials Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Company Advances Battery Materials Projects Cohen Circle Acquisition Corp II Warrant CCIIW Holds Steady at 075 Amid Tight Trading Range Beyond Air Inc XAIR Faces 25 Decline as Stock Tests Key Support at 041 National Presto Industries NPK Gains 22 as Defense Segment Lifts Sentiment RWAYI Holds Steady Near Support Runway Growth Finance Notes Show Resilience Amid Rate Uncertainty Willow Lane Acquisition Corp II Unit WLIIU Edges Higher as Investors Eye Support Levels Shopify SHOP Reaches 10655 as Positive Momentum Builds Toward 112 Resistance Webull Warrants BULLW Drop 95 as Selling Pressure Intensifies Dogwood Therapeutics Inches Lower as Stock Tests Key Support Near 169